Epidermal growth factor receptor-stimulated activation of phospholipase Cγ-1 promotes invasion of head and neck squamous cell carcinoma

Cancer Research

Volumn 63, Issue 17, 2003, Pages 5629-5635

  Thomas, Sufi Mary ^a   Coppelli, Francesca M ^a   Wells, Alan ^a,b   Gooding, William E ^a   Song, John ^a   Kassis, Jareer ^a,b   Drenning, Stephanie D ^a   Grandis, Jennifer Rubin ^a,c  

^a Department of Otolaryngology ^*  (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANTISENSE OLIGONUCLEOTIDE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; INOSITOL PHOSPHATE; MATRIGEL; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HEAD CANCER; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE METASTASIS; NECK CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 0141592701     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Kowalski, L. P., Bagietto, R., Lara, J. R., Santos, R. L., Silva, J. F., Jr., and Magrin, J. Prognostic significance of the distribution of neck node metastasis from oral carcinoma. Head Neck, 22: 207-214, 2000.
2. Grandis, J. R., and Tweardy, D. J. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53: 3579-3584, 1993.
3. Ishitoya, J., Toriyama, M., Oguchi, N., Kitamura, K., Ohshima, M., Asano, K., and Yamamoto, T. Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. Br. J. Cancer, 59: 559-562, 1989.
4. Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., and Tweardy, D. J. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J. Natl. Cancer Inst., 90: 824-832, 1998.
5. Wells, A. Tumor invasion: role of growth factor-induced cell motility. Adv. Cancer Res., 78: 31-101, 2000.
6. Thomas, S. M., and Grandis, J. R. Importance of epidermal growth factor receptor in head and neck cancer. Updates, 1: 1-11, 2001.
7. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell, 103: 211-225, 2000.
8. Tsang, D. K., and Crowe, D. L. The mitogen activated protein kinase pathway is required for proliferation but not invasion of human squamous cell carcinoma lines. Int. J. Oncol., 15: 519-523, 1999.
9. Gupta, A. K., McKenna, W. G., Weber, C. N., Feldman, M. D., Goldsmith, J. D., Mick, R., Machtay, M., Rosenthal, D. I., Bakanauskas, V. J., Cerniglia, G. J., Bernhard, E. J., Weber, R. S., and Muschel, R. J. Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. Clin. Cancer Res., 8: 885-892, 2002.
10. Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., and Tweardy, D. J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. Clin. Investig., 102: 1385-1392, 1998.
11. Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., and Kim, J. D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. USA, 97: 4227-4232, 2000.
12. Yokoi, T., Yamaguchi, T., Odajima, J., and Furukawa, K. Establishment and characterization of a human cell line derived from a squamous cell carcinoma of the tongue. Tumor Res., 23: 43-57, 1988.
13. Heo, D. S., Snyderman, C., Gollin, S. M., Pan, S., Walker, E., Deka, R., Barnes, E. L., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49: 5167-5175, 1989.
14. Zou, C. P., Youssef, E. M., Zou, C. C., Carey, T. E., and Lotan, R. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR β and on retinoid resistance in human squamous carcinoma cells. Oncogene, 20: 6820-6827, 2001.
15. Chen, P., Xie, H., Sekar, M. C., Gupta, K., and Wells, A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol., 127: 847-857, 1994.
16. Kassis, J., Moellinger, J., Lo, H., Greenberg, N. M., Kim, H. G., and Wells, A. A role for phospholipase C-γ-mediated signaling in tumor cell invasion. Clin. Cancer Res., 5: 2251-2260, 1999.
17. Rubin Grandis, J., Chakraborty, A., Melhem, M. F., Zeng, Q., and Tweardy, D. J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene, 15: 409-416, 1997.
18. Wells, A. EGF receptor. Int. J. Biochem. Cell Biol., 31: 637-643, 1999.
19. Li, N., Schlessinger, J., and Margolis, B. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene, 9: 3457-3465, 1994.
20. Song, J. I., and Grandis, J. R. STAT signaling in head and neck cancer. Oncogene, 19: 2489-2495, 2000.
21. Grandis, J. R., Zeng, Q., and Drenning, S. D. Epidermal growth factor receptor-mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope, 110: 868-874, 2000.
22. Turner, T., Chen, P., Goodly, L. J., and Wells, A. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin. Exp. Metastasis, 14: 409-418, 1996.
23. Turner, T., Epps-Fung, M. V., Kassis, J., and Wells, A. Molecular inhibition of phospholipase cγ signaling abrogates DU-145 prostate tumor cell invasion. Clin. Cancer Res., 3: 2275-2282, 1997.
24. Yoshizaki, T., Sato, H., Maruyama, Y., Murono, S., Furukawa, M., Park, C. S., and Seiki, M. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer (Phila.), 79: 139-144, 1997.
25. Imanishi, Y., Fujii, M., Tokumaru, Y., Tomita, T., Kanke, M., Kanzaki, J., Kameyama, K., Otani, Y., and Sato, H. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum. Pathol., 31: 895-904, 2000.
26. Riedel, F., Gotte, K., Schwalb, J., and Hormann, K. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res., 20: 3045-3049, 2000.
27. P. O. C., Rhys-Evans, P., Modjtahedi, H., Court, W., Box, G., and Eccles, S. Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int. J. Cancer, 86: 307-317, 2000.
28. P. O. c., Modjtahedi, H., Rhys-Evans, P., Court, W. J., Box, G. M., and Eccles, S. A. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res., 60: 1121-1128, 2000.
29. Shiratsuchi, T., Ishibashi, H., and Shirasuna, K. Inhibition of epidermal growth factor-induced invasion by dexamethasone and AP-1 decoy in human squamous cell carcinoma cell lines. J. Cell Physiol., 193: 340-348, 2002.
30. Arteaga, C. L., Johnson, M. D., Todderud, G., Coffey, R. J., Carpenter, G., and Page, D. L. Elevated content of the tyrosine kinase substrate phospholipase C-1 in primary human breast carcinomas. Proc. Am. Assoc. Cancer Res., 88: 10435-10439, 1991.
31. Johnson, M. D., Horiba, M., Winnier, A. R., and Arteaga, C. L. The epidermal growth factor receptor is associated with phospholipase C-γ 1 in meningiomas. Hum. Pathol., 25: 146-153, 1994.
32. Lee, S. J., Lee, S. D., Park, J. G., Kim, C. M., Ryu, S. H., and Suh, P. G. Overexpression of phospholipase C-γ 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter. J. Biol. Chem., 270: 16378-16384, 1995.
33. Nomoto, K., Tomita, N., Miyake, M., Xhu, D. B., LoGerfo, P. R., and Weinstein, I. B. Expression of phospholipases γ 1, β 1, and δ 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol. Carcinog., 12: 146-152, 1995.
34. Noh, D. Y., Lee, Y. H., Kim, S. S., Kim, Y. I., Ryu, S. H., Suh, P. G., and Park, J. G. Elevated content of phospholipase C-γ 1 in colorectal cancer tissues. Cancer (Phila.), 73: 36-41, 1994.